CPs rarely are the deciding factor in an approval as you know, and typically a ploy by the competition (in this case allergan has a hand in it since they own the rights to the medytox product). This particular CP for me was just educational - background about neurotoxin in general, and did have a very persuasive point about the veracity of the origin of the strain for daewoong I too think they probably have the Hall strain since this strain is one that seems to be suited for commercial purposes
Market Data 
Markets 
AI
